Category: Mergers & Acquisitions
The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.
A 2nd suitor for orthopedic device maker Biomet ceded the field early to Zimmer, regulatory filings show, but Biomet held out for better terms from its cross-town rival.
Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.
Baxter's has 'high' hopes for its coming Baxalta spinout, which will get a full visual work-up before the company goes live mid-2015.
Baxter (NYSE:BAX) crept a little closer to spinning out its biopharmaceuticals division into an independent entity by giving the company a name: Baxalta.
Japanese regulators are the latest to probe the pending merger of Biomet and Zimmer to make sure it meets anti-trust muster.
Preventice and eCardio agree to an alliance, combining their remote patient monitoring platforms and their sales teams under a new holding company.
Remote patient care company Preventice and remote cardiac monitoring devices maker eCardio Diagnostics announced this week that they would join forces and merge sales operations under a new holding company, Preventice Inc.
The new company combines Preventice's commercially available wireless remote cardiac monitoring systems with eCardio's national sales force and patient monitoring center.
Allergan confirmed late last week that it would call the shareholder meeting demanded by unsolicited buyers Valeant Pharmaceuticals and activist investor William Ackman.